Inozyme Pharma | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Sofinnova Venture Partners X, L.P. (“SVP X”)(6.9%),Sofinnova Management X, L.P. (“SM X LP”)(6.9%), etc.
Inozyme Pharma | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Sofinnova Venture Partners X, L.P. (“SVP X”)(6.9%),Sofinnova Management X, L.P. (“SM X LP”)(6.9%), etc.
Inozyme Pharma | SC 13D/A：超过5%持股股东披露文件(修正)-Sofinnova Venture Partners X, L.P. (“SVP X”)(6.9%),Sofinnova Management X, L.P. (“SM X LP”)(6.9%)等